Pro

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Anti-Cancer Agents & Biologic Therapy
Prostate Cancer
Presenter Karim Fizazi
Authors K. Fizazi
  • Department Of Cancer Medicine, Institut Gustave Roussy, 94805 - Villejuif/FR